Steatosis Rates by Liver Biopsy and Transient Elastography With Controlled Attenuation Parameter in Clinical Experience of Hepatitis C Virus (HCV) and Human Immunodeficiency Virus/HCV Coinfection in a Large US Hepatitis Clinic-Reference-Cited by-同舟云学术

Steatosis Rates by Liver Biopsy and Transient Elastography With Controlled Attenuation Parameter in Clinical Experience of Hepatitis C Virus (HCV) and Human Immunodeficiency Virus/HCV Coinfection in a Large US Hepatitis Clinic

Published:2019-03-01 Issue:4 Volume:6 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Sansom Sarah E¹²^ORCID,Martin Jonathan¹²,Adeyemi Oluwatoyin¹²,Burke Kerianne¹,Winston Crystal¹,Markham Sara¹,Go Benjamin¹,Huhn Gregory¹²

Affiliation:

1. Ruth M. Rothstein CORE Center, Chicago, Illinois

2. Rush University Medical Center, Chicago, Illinois

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Link

http://academic.oup.com/ofid/article-pdf/6/4/ofz099/28287793/ofz099.pdf

Reference40 articles.

1. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases;Chalasani;Hepatology,2018

2. Global perspectives on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis;Younossi;Hepatology,2018

3. Nonalcoholic fatty liver disease among HIV-infected persons;Crum-Cianflone;J Acquir Immune Defic Syndr,2009

4. Risk factors for fatty liver in the Multicenter AIDS Cohort Study;Price;Am J Gastroenterol,2014

5. Histological findings and clinical characteristics associated with hepatic steatosis in patients coinfected with HIV and hepatitis C virus;Marks;J Infect Dis,2005

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of intermittent fasting diet in comparison with low-calorie diet on lipid profile, glycemic status, and liver fibrosis in patients with non-alcoholic fatty liver (NAFLD): a study protocol for a randomized controlled clinical trial;BMC Nutrition;2023-12-08

2. Evaluating M2BPGi as a Marker for Liver Fibrosis in Patients with Chronic Hepatitis B;Digestive Diseases and Sciences;2023-10-20

3. Effect of HCV treatment with DAAs on serum intestinal fatty acid binding protein (I-FABP) as a marker of intestinal permeability in HCV/HIV co-infected patients;Egyptian Liver Journal;2023-04-29

4. Prevention of liver fibrosis and steatosis progression among heavy drinkers with and without HIV after 30-day drinking-reduction program;2023-03-01

5. Prevalence of metabolic dysfunction-associated fatty liver disease in kidney transplant recipients: A cross-sectional study using FibroScan;Hepatology Forum;2023